Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prazosin Treatment for Alcohol Use Disorder With Alcohol Withdrawal Symptoms

NCT04793685 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04793685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04793685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prazosin Treatment for Alcohol Use Disorder With Alcohol Withdrawal Symptoms
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2021
Completion date
June 30, 2026
Enrollment
152 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol withdrawal